This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice. 

Topics Covered

This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice. 

Esta actividad educativa se centra en las técnicas de delineación de volumen en radioterapia, específicamente para tumores del sistema nervioso central.

Join us for a series of informal engagement sessions designed to provide a space for open discussions and collaboration around mentorship, sponsorship and career transitions. These 30-minute online sessions are open to all ASTRO members and members-in-training.

This webinar focuses on reviewing the most recent literature that has been published on the use of low dose radiation for osteoarthritis. The discussion highlights the most recently presented and published studies including multiple prospective clinical trials.

Low-dose radiotherapy (LDRT) is gaining attention as a novel therapeutic approach for central nervous system (CNS) pathologies with inflammatory components, including Alzheimer's disease (AD) and other neurodegenerative disorders.

Through a series of complex clinical scenarios, this activity examines decision-making strategies, technical considerations, and outcome optimization in nonmalignant condition management.

There are many ongoing advances in the context of radiation therapy delivery for patients with primary soft tissue sarcoma of the extremity/trunk with emerging practice-changing clinical research and new treatment options, some of which are not yet standard of care.

This presentation reviews characteristic multimodality imaging features of soft tissue sarcoma (STS), discusses MRI imaging protocols, identifies imaging features of STS that may allow for a specific diagnosis or narrow the differential diagnosis, covers potential imaging pitfalls, and discusses

Angiosarcoma is rare, and often portends adverse outcomes. Those who receives multi-modal care generally experience the best cancer outcomes. However, guidelines to inform approach are limited. Further education is needed to advocate for high-quality care in this uncommon setting.